In the setting of primary prevention, elevated Lp(a) levels were associated with increased ASCVD risk, particularly in individuals with concomitant elevated hs-CRP levels and those at intermediate 10-year ASCVD risk. This evidence concerns the gene LPA and atherosclerosis.